指南与共识中毒与环境急症心脑血管急症

急性抗精神病药中毒的QT间期延长:系统评价与推荐

QT interval prolongation in acute antipsychotic poisoning: systematic review and recommendations.
指南 / 共识 · Clin Toxicol (Phila) · 2025-11-19
一句话结论工作组推荐所有急性抗精神病药过量者筛查心电图,仅对硫利达嗪、氨磺必利、齐拉西酮等高危过量者持续心电监护。

临床毒理学推荐协作组下设QT间期延长工作组,对全部急性过量QT间期延长文献进行系统评价,其中55篇涉及抗精神病药过量致QT间期延长,采用两轮改良Delphi法形成共识。工作组建议所有急性抗精神病药过量患者筛查心电图;推荐对氨磺必利>2 g、硫利达嗪>1 g、齐拉西酮>3 g的摄入持续心电监护;建议对上述药物较低剂量摄入以及氟哌啶醇、伊潘立酮、匹莫齐特、匹泮哌隆摄入持续心电监护;不建议对氯氮平、利培酮持续心电监护,不推荐对奥氮平、喹硫平因QT间期持续心电监护。讨论指出喹硫平、奥氮平、利培酮的尖端扭转型室速风险可能被高估,持续监护需结合药物、剂量、摄入时间、心率及合并摄入等个体化风险评估。

要点

  • 建议所有急性抗精神病药过量患者筛查心电图作为风险评估工具。
  • 推荐对摄入氨磺必利>2 g、硫利达嗪>1 g、齐拉西酮>3 g者持续心电监护。
  • 建议对上述药物较低剂量摄入及氟哌啶醇、伊潘立酮、匹莫齐特、匹泮哌隆摄入持续心电监护。
  • 不建议对急性氯氮平、利培酮中毒持续心电监护,不推荐对奥氮平、喹硫平因QT间期持续心电监护。
  • 持续监护需求应个体化评估药物与剂量、摄入时间、心率及合并摄入等因素。

适用人群与场景

  • 急性抗精神病药物过量中毒患者,涵盖氨磺必利、硫利达嗪、齐拉西酮、喹硫平、氯氮平、氟哌啶醇、伊潘立酮、匹莫齐特、匹泮哌隆、奥氮平、利培酮等药物摄入者。

处置流程与药物剂量

  • 建议所有急性抗精神病药摄入患者使用心电图作为风险评估工具。
  • 推荐对摄入氨磺必利>2 g、硫利达嗪>1 g、齐拉西酮>3 g的患者进行持续心电监护。
  • 建议对氨磺必利、硫利达嗪、齐拉西酮较低剂量摄入以及氟哌啶醇、伊潘立酮、匹莫齐特、匹泮哌隆摄入的患者进行持续心电监护。
  • 不建议对急性氯氮平和利培酮中毒进行持续心电监护。
  • 不推荐对急性奥氮平或喹硫平中毒因QT间期进行持续心电监护。
  • 持续心电监护的必要性应通过个体化风险评估决定,考虑药物和摄入剂量、摄入后时间以及心率或合并摄入等其他因素。

研究设计与关键结果

  • 系统评价共纳入327篇关于全部急性过量QT间期延长的文献,其中55篇与急性抗精神病药所致QT间期延长相关。
  • 对文献数>3篇的药物逐一给出推荐:氨磺必利15篇、硫利达嗪11篇、齐拉西酮8篇、喹硫平13篇;对文献数<3篇的药物合并为 miscellaneous 讨论,包括氯氮平、氟哌啶醇、伊潘立酮、匹莫齐特、匹泮哌隆、奥氮平、利培酮共14篇,基于有限数据形成共识声明。
  • 推荐对氨磺必利>2 g、硫利达嗪>1 g、齐拉西酮>3 g摄入者持续心电监护;建议对上述药物较低剂量摄入及氟哌啶醇、伊潘立酮、匹莫齐特、匹泮哌隆摄入者持续心电监护。
  • 不建议对急性氯氮平、利培酮中毒持续心电监护;不推荐对急性奥氮平或喹硫平中毒因QT间期持续心电监护。
  • 心电图被建议作为所有抗精神病药摄入的风险评估工具;持续心电监护需求应基于药物与剂量、摄入后时间、心率或合并摄入等个体化风险评估。

证据类型、等级与局限

  • 证据类型:系统评价联合两轮改良Delphi法共识,采用RAND/UCLA Appropriateness Method定义的分歧指数衡量共识强度。
  • 不同抗精神病药致QT间期延长和尖端扭转型室速风险证据质量异质,固有地限制了推荐强度。
  • 现有数据提示氨磺必利、硫利达嗪和齐拉西酮与QT间期延长及尖端扭转型室速相关,而喹硫平、奥氮平和利培酮的风险可能被高估。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对急性抗精神病药过量患者,常规筛查心电图以评估QT间期延长风险。
  • 对氨磺必利>2 g、硫利达嗪>1 g、齐拉西酮>3 g摄入者启动持续心电监护;对上述药物较低剂量及氟哌啶醇、伊潘立酮、匹莫齐特、匹泮哌隆摄入者建议持续心电监护。
  • 对急性氯氮平、利培酮中毒不建议持续心电监护;对急性奥氮平或喹硫平中毒不推荐因QT间期持续心电监护。
  • 不应将抗精神病药物作为整体类别过度担忧尖端扭转型室速风险,而应聚焦于少数特定药物。

指南或共识出处

  • QT Interval Prolongation in Clinical Toxicology Workgroup(临床毒理学推荐协作组)制定的系统评价与推荐,发表于 Clin Toxicol (Phila)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Antipsychotic medications are often associated with QT interval prolongation, which can lead to ventricular dysrhythmias, including torsade de pointes. However, unstable or significant dysrhythmic events are rare. Evidence-based recommendations on the assessment and management of poisoned patients at risk for QT interval prolongation are lacking. Current practice often involves costly and lengthy cardiac monitoring, leading to delayed disposition of the patient from emergency departments or prolonged monitoring times in other hospital units. To address this issue, the QT Interval Prolongation in Clinical Toxicology Workgroup was formed by the Clinical Toxicology Recommendations Collaborative to develop evidence-based recommendations for the management and treatment of QT interval prolongation in acute overdose patients. This article reports our findings on patients with antipsychotic poisoning.

METHODS: A systematic review of the literature regarding QT interval prolongation in all acute overdoses was undertaken, and the evidence was summarized for antipsychotic medication overdose. Voting statements were drafted using a predetermined format for monitoring the QT interval and use of continuous cardiac monitoring. A two-round modified Delphi method was used to reach a consensus. The strength of consensus was measured using the disagreement index as defined by the RAND/UCLA Appropriateness Method.

RESULTS: From the 327 articles that were included in the systematic review of QT interval prolongation in all acute overdoses, a total of 55 articles were relevant to antipsychotic medication-induced QT prolongation in acute overdose. Medications with more than three articles were reviewed individually for recommendations, whilst medications with less than three were grouped together for discussion as miscellaneous. Individual medication recommendations were made for amisulpride (15 articles), thioridazine (11 articles), ziprasidone (eight articles) and quetiapine (13 articles), whilst consensus statements based on limited data were made for acute ingestions of clozapine, haloperidol, iloperidone, pimozide, pipamperone, olanzapine and risperidone (14 articles in total). The electrocardiogram is suggested as a risk assessment tool for ingestion of all antipsychotic medication. We recommend continuous cardiac monitoring for patients ingesting more than amisulpride 2 g, thioridazine 1 g, and ziprasidone 3 g. We suggest continuous cardiac monitoring for the above-mentioned medications for lower dose ingestions as well as for ingestions of haloperidol, iloperidone, pimozide and pipamperone. We do not suggest continuous cardiac monitoring for acute clozapine and risperidone poisoning, and do not recommend continuous cardiac monitoring for the QT interval in acute olanzapine or quetiapine poisoning. The need for ongoing cardiac monitoring should be guided by an individual risk assessment considering the medication and dose ingested, the time since ingestion, as well as other factors such as heart rate or co-ingestions.

DISCUSSION: The quality of evidence for the risk of QT interval prolongation and torsade de pointes is heterogeneous among different antipsychotics and inherently constrains the recommendations. Available data suggest that amisulpride, thioridazine and ziprasidone are associated with QT interval prolongation and torsade de pointes, while the risk is likely overstated for quetiapine, olanzapine and risperidone. Ongoing research is needed to improve management strategies for acute antipsychotic overdose-induced QT interval prolongation and dysrhythmias.

CONCLUSIONS: The QT Interval Prolongation in Clinical Toxicology Workgroup recommends the use of screening electrocardiograms in all patients with acute antipsychotic medication overdose and cardiac monitoring in patients with at-risk overdoses from thioridazine, amisulpride, and ziprasidone. The QT Interval Prolongation in Clinical Toxicology Workgroup suggests the same approach for patients with overdoses of haloperidol, iloperidone, pipamperone and pimozide. The risk of torsade de pointes is likely overstated for acute antipsychotic medication overdose as a general class group, and concern should rather focus on a few specific medications.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Berling I, Yates C, Hoffman RS, et al. QT interval prolongation in acute antipsychotic poisoning: systematic review and recommendations. Clin Toxicol (Phila). 2025. PMID: 41255343. doi:10.1080/15563650.2025.2554950

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。